The Chemours Company (CC) Stock Overview
Explore The Chemours Company’s financial performance, market position, analyst ratings, and future outlook.
The Chemours Company (CC)
Key Financials
Key Financials
Market Cap
2.3B
P/E Ratio
-7.64
EPS (TTM)
$0.72
ROE
-1.70%
CC Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of The Chemours Company (NYSE: CC) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, The Chemours Company's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CC on the NYSE shows an RSI of 39.64, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $20.22 for the NYSE listing.
Key metrics behind The Chemours Company's NYSE-traded stock include a P/E ratio of -7.64 and a market capitalization of 2.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CC on the NYSE.